Shares of Gem Aromatics Limited made a muted yet positive debut on Tuesday, opening at ₹333.10 per share, reflecting a 2.5% gain over the IPO price of ₹325. For retail investors, this meant a profit of ₹372.6 per lot, while small HNI applicants booked ₹5,216.4 per lot on listing.
About Gem Aromatics
Gem Aromatics is a leading manufacturer of specialty ingredients, essential oils, aroma chemicals, and value-added derivatives, with a track record of more than two decades. Its wide product mix caters to diverse industries, including oral care, cosmetics, nutraceuticals, pharmaceuticals, wellness, pain relief, and personal care.
According to its Red Herring Prospectus (RHP), the company holds a strong market position in the essential oil segment, producing derivatives sourced from mint, clove, eucalyptus, and orange oils. Key product categories include mint oil, clove oil, eugenol, and eucalyptus oil.
Market position and performance
In FY2025, Gem Aromatics emerged among the top buyers of piperita oil and ranked as a leading processor of essential oil-based compounds like DMO, clove oil, eugenol, and eucalyptus oil. The company held a 12% domestic market share in DMO and a commanding 65% share in eugenol by volume, underscoring its strong presence in the segment.
